Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.49 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.47 |
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.41 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.40 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.40 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.39 |
| ▸ | RRM1 | P23921 | 1/20 | 0.39 |
| ▸ | FURIN | P09958 | 2/20 | 0.38 |
| ▸ | MME | P08473 | 1/20 | 0.38 |
| ▸ | CTSD | P07339 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30767177 | 1.00 | NOD1 (0.49) | NOD1DPP7DPP4DPP8DPP9 | |
| SCHEMBL30942562 | 0.92 | NOD1 (0.56) | NOD1DPP7DPP4DPP8DPP9 | |
| SCHEMBL29594367 | 0.92 | NOD1 (0.56) | NOD1DPP7DPP4DPP8DPP9 | |
| SCHEMBL29580013 | 0.91 | NOD1 (0.41) | NOD1DPP7SMN1; SMN2C3AR1FURIN | |
| SCHEMBL29371278 | 0.90 | GNAI3 (0.44) | NOD1DPP7DPP8DPP9GNAI3 | |
| SCHEMBL29533710 | 0.88 | BACE1 (0.46) | NOD1DPP4DPP8DPP9CTSD | |
| SCHEMBL29376100 | 0.88 | BACE1 (0.48) | NOD1DPP4DPP8DPP9CTSD | |
| SCHEMBL29388901 | 0.88 | C3AR1 (0.41) | NOD1C3AR1FURINCTSDBACE1 | |
| SCHEMBL30477363 | 0.88 | BACE1 (0.46) | NOD1CTSDBACE1 | |
| SCHEMBL29371801 | 0.87 | GNPAT (0.41) | NOD1C3AR1FURINCTSDBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034236-A1 | NEW DRUG COMPLEX | KOWA COMPANY, LTD. (JP) | 2026-02-05 | — | — | US | disclosed |
| EP-4570272-A1 | NEW DRUG COMPLEX | KOWA COMPANY, LTD. (JP) | 2025-06-18 | — | — | EP | disclosed |
| CN-119698305-A | New pharmaceutical complex | 兴和株式会社 | 2025-03-25 | — | — | CN | disclosed |
| WO-2024034684-A1 | NEW DRUG COMPLEX | 興和株式会社 | 2024-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034236-A1 | NEW DRUG COMPLEX | OPRM1, ABCC1, OPRD1 | NOD1 863/4885DPP7 3731/4885DPP4 3918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.